Introduction Hopes related to esketamine have been raised by its approval for treatment-resistant major depression (TRD) in the sense that this antidepressant, with a novel mechanism of action, will be useful for patients with bipolar depression (BD), too. The need to find more evidence-based pharma...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!